PUBLISHER: BCC Research | PRODUCT CODE: 1590306
PUBLISHER: BCC Research | PRODUCT CODE: 1590306
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
The North American market for single-use technologies for biopharmaceuticals is expected to grow from $2.0 billion in 2024 and is projected to reach $3.4 billion by the end of 2029, at a CAGR of 10.6% during the forecast period of 2024 to 2029.
The Asia-Pacific market for single-use technologies for biopharmaceuticals is expected to grow from $1.8 billion in 2024 and is projected to reach $3.3 billion by the end of 2029, at a CAGR of 13.3% during the forecast period of 2024 to 2029.
This report summarizes the single-use technologies market, including a market snapshot and company profiles of key players. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical market players' financials, product portfolios and recent activities.
BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading companies in the biopharmaceutical single-use technologies industry, including Sartorius AG, Danaher Corp, Merck KGaA and Thermo Fisher Scientific Inc.
The market is segmented by geographical region into North America, Europe, Asia-Pacific and the Rest of the World (RoW). Regional analysis is further broken down by country as:
Data for market estimates have been provided for 2021 and 2022 as the historical years, 2023 as the base year and forecast through 2029.